These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients. Singh N; Heitman J Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients. Stergiopoulou T; Walsh TJ Expert Opin Pharmacother; 2015 Feb; 16(2):213-26. PubMed ID: 25579070 [TBL] [Abstract][Full Text] [Related]
8. Clinically relevant drug interactions of current antifungal agents. Gubbins PO; Heldenbrand S Mycoses; 2010 Mar; 53(2):95-113. PubMed ID: 20002883 [TBL] [Abstract][Full Text] [Related]
9. The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents. Andriole VT J Antimicrob Chemother; 1999 Aug; 44(2):151-62. PubMed ID: 10473222 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of Conventional Antifungal Agents against Recombinant Yeast Overexpressing β-1,3-Glucanase]. Kida A; Ikeda T; Seto H; Iida Y Yakugaku Zasshi; 2018; 138(6):837-842. PubMed ID: 29863056 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents. Vandekerckhove S; Tran HG; Desmet T; D'hooghe M Bioorg Med Chem Lett; 2013 Aug; 23(16):4641-3. PubMed ID: 23838261 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of systemic antifungal agents. Elewski BE J Am Acad Dermatol; 1993 May; 28(5 Pt 1):S28-S34. PubMed ID: 8496409 [TBL] [Abstract][Full Text] [Related]
13. Changes in the utilization patterns of antifungal agents, medical cost and clinical outcomes of candidemia from the health-care benefit expansion to include newer antifungal agents. Choi H; Kim JH; Seong H; Lee W; Jeong W; Ahn JY; Jeong SJ; Ku NS; Yeom JS; Kim YK; Kim HY; Song YG; Kim JM; Choi JY Int J Infect Dis; 2019 Jun; 83():49-55. PubMed ID: 30959246 [TBL] [Abstract][Full Text] [Related]
14. [Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies]. Ji Y; Xu LP; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):473-7. PubMed ID: 23827099 [TBL] [Abstract][Full Text] [Related]
15. Common drug-drug interactions in antifungal treatments for superficial fungal infections. Gupta AK; Versteeg SG; Shear NH Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):387-398. PubMed ID: 29633864 [TBL] [Abstract][Full Text] [Related]
16. An audit of the use of antifungal agents. Gutiérrez F; Wall PG; Cohen J J Antimicrob Chemother; 1996 Jan; 37(1):175-85. PubMed ID: 8647761 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of calcium channel blockers in combination with conventional antifungal agents against clinically important filamentous fungi. Homa M; Hegedűs K; Fülöp Á; Wolfárt V; Kadaikunnan S; Khaled JM; Alharbi NS; Vágvölgyi C; Galgóczy L Acta Biol Hung; 2017 Sep; 68(3):334-344. PubMed ID: 28901803 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of mechanisms of antifungal drug resistance in yeasts. Sanglard D Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):462-9; quiz 470, 479. PubMed ID: 12425880 [TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity of antifungal agents. Song JC; Deresinski S Curr Opin Investig Drugs; 2005 Feb; 6(2):170-7. PubMed ID: 15751740 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory properties of antifungal agents on phagocytic cells. Simitsopoulou M; Roilides E; Walsh TJ Immunol Invest; 2011; 40(7-8):809-24. PubMed ID: 21985307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]